P1–338: Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC‐001]) and the QS‐21 adjuvant in Japanese individuals with mild‐to‐moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial. (1st July 2013) - Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu, Enchi; Ketter, Nzeera; Margolin, Richard; Jackson, Nicholas; Fujimoto, Yoko